DxS Expands in US with Appointment of Jane Papadaki-Markley as Sales and Marketing Director for North America
DxS Ltd has announced the appointment of Jane Papadaki-Markley as Sales and Marketing Director as it expands in North America. Jane is based in California and will be responsible for the continued expansion of DxS’ tumour mutation analysis products in the US and Canada.
Jane joins DxS from Agendia, Inc, a cancer diagnostic company specialising in validated diagnostic tests where she was Senior Director of Sales and Marketing. She previously worked for Focus Diagnostics/Quest for over 20 years in a wide-ranging role encompassing Sales and Marketing, Technical Advisory and Business Development.
The appointment is one of a number planned for 2009 continuing DxS’ planned expansion which has seen the company’s workforce more than double in size in the last twelve months with new manufacturing space taken at their Manchester site and a global distribution deal agreed with Roche Molecular Diagnostics.
Other news from the department people
